| Revenue: | $1.2B |
| Operating Profit: | -$23.0M |
| Profit After Tax: | -$48.0M |
| Total Assets: | $1.5B |
| Shareholders' Equity: | -$205.0M |
| Current Ratio: | 0.88 |
| Operating Cash Flow: | $23.0M |
As at Dec 20245 years of data
| 3 Aug 2026 | 11:31:00 | Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance |
| 23 Jul 2026 | 15:00:00 | Indivior to Report Second Quarter 2026 Financial Results and Host Webcast |
| 20 May 2026 | 14:00:00 | New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization |
| 14 May 2026 | 12:00:00 |
| 17 Mar 2025 | Annual Report and Accounts 2024 (ESEF Version) | |
| 14 Mar 2024 | Indivior PLC Annual Report and Accounts 2023 (ESEF Version) | |
| 13 Mar 2024 | Annual Report and Accounts for year ended 31 December, 2023. |
Indivior is a multinational pharmaceutical corporation dedicated to improving the lives of patients by developing innovative treatments for substance use disorders and other severe mental illnesses.
| 3 Aug 2026 | 11:31:00 | Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance |
| 23 Jul 2026 | 15:00:00 | Indivior to Report Second Quarter 2026 Financial Results and Host Webcast |
| 20 May 2026 | 14:00:00 | New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization |
| 14 May 2026 | 12:00:00 |
| 17 Mar 2025 | Annual Report and Accounts 2024 (ESEF Version) | |
| 14 Mar 2024 | Indivior PLC Annual Report and Accounts 2023 (ESEF Version) | |
| 13 Mar 2024 | Annual Report and Accounts for year ended 31 December, 2023. |
Indivior is a multinational pharmaceutical corporation dedicated to improving the lives of patients by developing innovative treatments for substance use disorders and other severe mental illnesses.
| 4 May 2026 | 12:00:00 | Indivior Announces $175 Million Accelerated Share Repurchase |
| 4 May 2026 | 12:00:00 | Indivior Announces $175 Million Accelerated Share Repurchase |
